|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: AMERICAN MEDICAL TECHNOLOGIES INC/DE, 10-Q, EX-4.2, 2000-11-08 |
Next: AMBAC FINANCIAL GROUP INC, SC 13G/A, 2000-11-08 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 1,741,863
<SECURITIES> 0
<RECEIVABLES> 3,576,051
<ALLOWANCES> 175,000
<INVENTORY> 9,889,025
<CURRENT-ASSETS> 16,856,228
<PP&E> 4,875,951
<DEPRECIATION> 2,440,542
<TOTAL-ASSETS> 36,149,618
<CURRENT-LIABILITIES> 2,074,403
<BONDS> 0
0
0
<COMMON> 291,882
<OTHER-SE> 30,426,926
<TOTAL-LIABILITY-AND-EQUITY> 36,149,618
<SALES> 14,588,293
<TOTAL-REVENUES> 14,747,715
<CGS> 7,076,049
<TOTAL-COSTS> 7,076,049
<OTHER-EXPENSES> 8,379,398
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 266,633
<INCOME-PRETAX> (895,772)
<INCOME-TAX> (40,000)
<INCOME-CONTINUING> (855,772)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (855,772)
<EPS-BASIC> (0.12)
<EPS-DILUTED> (0.12)
</TABLE>
|
|